Revision as of 10:59, 17 February 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report [[Wik← Previous edit | Revision as of 11:56, 4 April 2011 edit undoLouisajb (talk | contribs)Extended confirmed users4,402 edits added the data from COLCEMID PAGENext edit → | ||
Line 40: | Line 40: | ||
}} | }} | ||
'''Demecolcine''' is a drug used in ].It is closely related to the natural ] ] with the replacement of the ] group on the ] moiety with ]. | '''Demecolcine''', also known as colcemid, is a drug used in ].It is closely related to the natural ] ] with the replacement of the ] group on the ] moiety with ], but it is less toxic. It ] ] and limits microtubule formation (inactivates ] formation), thus arresting ]s in ] and allowing cell harvest and ] to be performed. | ||
During cell division Demecolcine inhibits mitosis at metaphase by inhibiting spindle formation. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.<ref>Brit med J., 1965, 1, 495 – 496</ref> | During cell division Demecolcine inhibits mitosis at metaphase by inhibiting spindle formation. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.<ref>Brit med J., 1965, 1, 495 – 496</ref> | ||
In animal cloning procedures Demecolcine makes an ovum eject its nucleus, creating space for insertion of a new nucleus.<ref>Reprod Nutr Dev. 2006 Mar-Apr;46(2):219-26</ref> | In animal cloning procedures Demecolcine makes an ovum eject its nucleus, creating space for insertion of a new nucleus.<ref>Reprod Nutr Dev. 2006 Mar-Apr;46(2):219-26</ref> | ||
==Mechanism of Action== | |||
Demecolcine is a microtubule-depolymerizing drug like ]. It acts by two distinct mechanisms. At very low concentration it binds to microtubule plus end to suppress microtubule dynamics.<ref>{{cite journal |last1=Jordan |first1=Mary Ann |last2=Wilson |first2=Leslie |title=Microtubules as a target for anticancer drugs |journal=Nature reviews. Cancer |volume=4 |issue=4 |pages=253–65 |year=2004 |pmid=15057285 |doi=10.1038/nrc1317}}</ref> Recent study has found at higher concentration colcemid can promote microtubule detachment from microtubule organizing center. Detached microtubules with unprotected minus end depolymerizes with time. Cytotoxicity of the cells seems to correlate better with ] detachment.<ref name=pmid20696757>{{cite journal |last1=Yang |first1=Hailing |last2=Ganguly |first2=Anutosh |last3=Cabral |first3=Fernando |title=Inhibition of cell migration and cell division correlate with distinct effects of microtubule inhibiting drugs |journal=The Journal of biological chemistry |volume=285 |issue=42 |pages=32242–50 |year=2010 |pmid=20696757 |pmc=2952225 |doi=10.1074/jbc.M110.160820}}</ref> Lower concentration affects microtubule dynamics and cell migration.<ref name=pmid20696757/> | |||
== References == | == References == | ||
Line 54: | Line 57: | ||
] | ] | ||
] | ] | ||
] | |||
] | |||
Revision as of 11:56, 4 April 2011
Pharmaceutical compoundClinical data | |
---|---|
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.832 |
Chemical and physical data | |
Formula | C21H25NO5 |
Molar mass | 371.43 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Demecolcine, also known as colcemid, is a drug used in chemotherapy.It is closely related to the natural alkaloid colchicine with the replacement of the acetyl group on the amino moiety with methyl, but it is less toxic. It depolymerises microtubules and limits microtubule formation (inactivates spindle fibre formation), thus arresting cells in metaphase and allowing cell harvest and karyotyping to be performed.
During cell division Demecolcine inhibits mitosis at metaphase by inhibiting spindle formation. Medically Demecolcine has been used to improve the results of cancer radiotherapy by synchronising tumour cells at metaphase, the radiosensitive stage of the cell cycle.
In animal cloning procedures Demecolcine makes an ovum eject its nucleus, creating space for insertion of a new nucleus.
Mechanism of Action
Demecolcine is a microtubule-depolymerizing drug like vinblastine. It acts by two distinct mechanisms. At very low concentration it binds to microtubule plus end to suppress microtubule dynamics. Recent study has found at higher concentration colcemid can promote microtubule detachment from microtubule organizing center. Detached microtubules with unprotected minus end depolymerizes with time. Cytotoxicity of the cells seems to correlate better with microtubule detachment. Lower concentration affects microtubule dynamics and cell migration.
References
- Brit med J., 1965, 1, 495 – 496
- Reprod Nutr Dev. 2006 Mar-Apr;46(2):219-26
- Jordan, Mary Ann; Wilson, Leslie (2004). "Microtubules as a target for anticancer drugs". Nature reviews. Cancer. 4 (4): 253–65. doi:10.1038/nrc1317. PMID 15057285.
- ^ Yang, Hailing; Ganguly, Anutosh; Cabral, Fernando (2010). "Inhibition of cell migration and cell division correlate with distinct effects of microtubule inhibiting drugs". The Journal of biological chemistry. 285 (42): 32242–50. doi:10.1074/jbc.M110.160820. PMC 2952225. PMID 20696757.
{{cite journal}}
: CS1 maint: unflagged free DOI (link)
This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it. |